SAB Biotherapeutics, Inc.

NASDAQ
SABS
Stock
Yield per half year: -16.99%
Dividend yield: 0%
Sector: Healthcare

Reporting SAB Biotherapeutics, Inc.

Capitalization

2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.0426 0.1079 0.0045 0.0517 -52.73
Выручка, млрд $
0.0034 0.0552 0.0609 0.0239 0.0022 0.0013 0.0013 0.0287 -52.75
Чистая прибыль, млрд $
-0.0094 0.0201 -0.0174 -0.0187 -0.0422 -0.0341 -0.0341 -0.0185 -211.15
EV, млрд $
0.0013 -0.0045 0.1871 -0.0066 -0.0467 0.0309 0.0309 0.0320 -247.01
EBIT, млрд $
-0.0087 0.0206 -0.0134 -0.0184 -0.0419 -0.0338 -0.0338 -0.0174 -210.41
EBITDA, млрд $
-0.0082 0.0211 -0.0117 -0.0151 -0.0381 -0.029 -0.029 -0.0146 -206.57
OIBDA, млрд $
0.0216 -0.0077 -0.0253 -0.034 -0.0378 -0.0378 -0.0166 -211.84
Баланс стоимость, млрд $
-0.0023 0.039 0.0385 0.0311 0.0573 0.026 0.026 0.0384 -7.79
FCF, млрд $
-0.0098 -0.0027 -0.0072 -0.0072 -0.0253 -0.0346 -0.0346 -0.0154 66.55
Операционный денежный поток, млрд $
-0.0092 0.01 0.0038 0.0038 -0.0251 -0.0343 -0.0343 -0.0084 -227.96
Операционная прибыль, млрд $
-0.0087 0.0206 -0.0134 -0.0289 -0.0381 -0.0429 -0.0429 -0.0205 -215.80
Операционные расходы, млрд $
0.0121 0.0347 0.0134 0.0289 0.0366 0.0429 0.0429 0.0313 4.33
CAPEX, млрд $
0.000609 0.0127 0.0109 0.0109 0.000197 0.000337 0.000337 0.0070 -51.61


Balance sheet

2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0063 0.0126 0.0332 0.015 0.0566 0.0089 0.0089 0.0253 -6.72
Short Term Investments $
0.0119 0.0119 0.0119 0.00
Total Receivables $
0.0028 0.0206 0.008 0.0056 0.0001 0.0001 0.0074 -48.65
Total Current Assets $
0.0093 0.0345 0.0484 0.0221 0.0589 0.0238 0.0238 0.0375 -7.16
Чистые активы, млрд $
0.0087 0.0221 0.0309 0.0233 0.0233 0.0213 27.93
Активы, млрд $
0.018 0.0565 0.0794 0.0509 0.0839 0.0442 0.0442 0.0630 -4.79
Short Term Debt $
0.0019 0.0017 0.0013 0.002 0.0019 0.000812 0.000812 0.0015 -13.74
Long Term Debt $
0.0001 0.000172 0.000542 0.000542 0.0003 75.66
Задолженность, млрд $
0.0203 0.0175 0.0408 0.0198 0.0266 0.0182 0.0182 0.0246 0.79
Чистый долг, млрд $
0.0013 -0.0045 -0.0265 -0.0091 -0.0507 -0.0042 -0.0042 -0.0190 -1.37
Долг, млрд $
0.0076 0.0081 0.0067 0.0059 0.0059 0.0047 0.0047 0.0063 -10.31
Interest income $
0.000113 0.0000 0.0000 0.0001 0.000131 0.0001 5.05
Расходы на обслуживание долга $
0.000428 0.000469 0.000294 0.000302 0.000315 0.000318 0.000318 0.0003 -7.48
Чист. проц. доходы, млрд $
0.000113 0.0000 0.0000 0.0001 0.000131 0.000131 0.0001 5.05
Амортизация, млрд $
0.000439 0.000578 0.0017 0.0033 0.0037 0.0048 0.0048 0.0028 52.71
Себестоимость, млрд $
0.0017 0.0033 0.0037 0.0048 0.0048 0.0034 29.63


Share

2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.2166 0.4627 -0.6381 -4.31 -7.64 -3.68 -3.68 -3.1611 -251.39
Цена акции ао 9.79 0.59 0.688 3.79 1.71 1.71 3.31 -29.46
Число акций ао, млн 43.47 43.47 27.34 4.35 5.52 9.26 9.26 17.99 -26.60
FCF/акцию -0.226 -0.0627 -0.2628 -1.65 -4.59 -3.74 -3.74 -2.0611 126.53


Efficiency

2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 408.46 109.63 -44.98 -53.85 -95.51 -81.92 -81.92 17.60 -33.3260 -194.34
ROA, % -52.31 53.98 -25.67 -28.77 -62.58 -53.23 -53.23 5.71 -23.2540 -199.72
ROS, % -273.62 36.42 -28.66 -78.4 -1884.5 -2579.03 -2579.03 -2579.03 13.36 -1429.9240 145.94
ROCE, % -64.8 45.2 -24.49 -51.27 -57.27 -93.29 -130.1 -130.1 29.73 -71.2840 39.66
Ebit margin, % -252.01 37.27 -22 -77.03 -1870.42 -2554.95 -2554.95 -2554.95 18.53 -1415.8700 158.82
Рентаб EBITDA, % -239.25 38.26 -19.24 -63.26 -1703.14 -2192.54 -2192.54 -2192.54 26.10 -1234.1440 157.84
Чистая рентаб, % -273.62 36.42 -28.66 -78.4 -1884.5 -2579.03 -2579.03 13.36 -906.8340 -334.44
Operation Margin, % -252.01 37.22 -22 -120.97 -1700.56 -3244.87 -3244.87 -3244.87 16.64 -1666.6540 171.49
Доходность FCF, % -16.87 -6.66 -564.61 -196.0467 222.26


Coefficients

2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-2.44 -5.76 -0.1063 69.12 -2.7688 -64.81
P/BV
5.54 0.0827 0.0684 1.35 1.35 8.87 1.76 -29.74
P/S
3.51 0.1074 1.75 26.57 26.57 8.05 7.98 65.87
P/FCF
-5.93 -15.02 0 0 0 0 8.97 -10.4750 59.15
E/P
-0.4097 -0.1737 -9.41 0 0 0 0.03 -3.3311 184.25
EV/EBIT
-0.1489 -0.2178 0.3816 0.3557 1.12 -0.9149 -0.9149 -0.9149 88.11 0.0055 -219.11
EV/EBITDA
-0.1569 -0.2122 -15.97 0.4332 1.23 -1.07 -1.07 53.63 -3.1178 38.21
EV/S
0.3753 -0.0812 -0.084 -0.274 -20.87 23.38 23.38 23.38 8.36 5.11 -408.26
EV/FCF
-0.1315 1.64 0.7113 0.9116 1.85 -0.8927 -0.8927 -0.8927 21.77 0.3375 -204.65
Debt/EBITDA
-0.2429 0.3845 -0.5759 -0.3921 -0.1549 -0.161 -0.161 -0.161 2.61 -0.2890 -22.50
Netdebt/Ebitda
-0.1569 -0.2122 2.26 0.603 1.33 0.1459 0.1459 0.1459 0.49 0.8970 -42.19
Debt/Ratio
0.1111 0.0324 0.085 0.1165 0.0704 0.1056 0.1056 0.1056 0.24 0.0966 4.44
Debt/Equity
-0.8674 0.0469 0.1749 0.1909 0.1031 0.1798 0.7018 0.7018 2.82 0.2701 32.03
Debt/Net Income
-0.2124 0.091 -0.3866 -0.3164 -0.14 -0.1369 -0.1369 -0.1369 10.75 -0.2234 -18.75
PEG
0 0 -67.37
Бета
-0.9671 5.49 0.0315 0.0315 0.01 1.52 -131.94
Индекс Альтмана
-0.0856 -0.7925 -2.11 -1.28 -2.78 -2.78 12.59 -1.4096 100.59


Dividends

LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.71


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Other

2020 2021 2022 2023 2024 LTM CAGR 5
CAPEX/Выручка, %
23.05 17.98 45.78 8.81 25.5 25.5 2.04
Персонал, чел
56 56 0.00